12/4
08:59 am
lly
Rating for LLY
Low
Report
Rating for LLY
12/4
08:59 am
lly
Rating for LLY
Low
Report
Rating for LLY
12/3
08:05 am
lly
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/3
08:05 am
lly
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/2
11:13 am
lly
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Low
Report
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
12/1
11:04 am
lly
Eli Lilly and Company (NYSE:LLY) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Eli Lilly and Company (NYSE:LLY) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
11/24
11:18 am
lly
Rating for LLY
Low
Report
Rating for LLY
11/24
11:18 am
lly
Rating for LLY
Low
Report
Rating for LLY
11/24
10:06 am
lly
Rating for LLY
Low
Report
Rating for LLY
11/24
10:06 am
lly
Rating for LLY
Low
Report
Rating for LLY
11/24
07:20 am
lly
Eli Lilly and Company (NYSE:LLY) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Eli Lilly and Company (NYSE:LLY) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
11/24
07:20 am
lly
Eli Lilly and Company (NYSE:LLY) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Eli Lilly and Company (NYSE:LLY) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
11/24
07:19 am
lly
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
11/18
10:33 am
lly
Rating for LLY
Low
Report
Rating for LLY
11/14
07:52 am
lly
Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Low
Report
Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
11/14
07:52 am
lly
Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Low
Report
Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
11/13
09:53 am
lly
Eli Lilly and Company (NYSE:LLY) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $1,165.00 price target on the stock.
Low
Report
Eli Lilly and Company (NYSE:LLY) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $1,165.00 price target on the stock.
11/13
09:53 am
lly
Eli Lilly and Company (NYSE:LLY) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $1,165.00 price target on the stock.
Low
Report
Eli Lilly and Company (NYSE:LLY) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $1,165.00 price target on the stock.
11/13
08:07 am
lly
Rating for LLY
Low
Report
Rating for LLY
11/13
08:07 am
lly
Rating for LLY
Low
Report
Rating for LLY
11/12
04:18 pm
lly
Eli Lilly initiated with an Outperform at Scotiabank
Low
Report
Eli Lilly initiated with an Outperform at Scotiabank
11/12
04:18 pm
lly
Eli Lilly initiated with an Outperform at Scotiabank
Low
Report
Eli Lilly initiated with an Outperform at Scotiabank
11/12
03:15 pm
lly
Rating for LLY
Low
Report
Rating for LLY
11/12
03:15 pm
lly
Rating for LLY
Low
Report
Rating for LLY
11/10
08:03 am
lly
Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $1,104.00 price target on the stock, up previously from $886.00.
Medium
Report
Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $1,104.00 price target on the stock, up previously from $886.00.